L

Laronde

153 employees

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical

Date founded

2017

Funding rounds raised

Total raised

$440M

from 5 investors over 5 rounds

L

Laronde raised $440M on August 30, 2021

Investors: The Invus Group, T. Rowe Price, Longevity Vision Fund and Flagship Ventures

L

Laronde raised $50M on May 10, 2021

Investors: Flagship Ventures

FAQ